ARTICLE | Clinical News
Proteolix preclinical data
June 22, 2009 7:00 AM UTC
In mouse models of rheumatoid arthritis (RA), PR-957 reversed signs of disease and reduced cellular infiltration, cytokine production and autoantibody levels. In vitro and in vivo, PR-957 blocked pres...